Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Brian Rood"'
Autor:
Zhichao Wu, Sharika Rajan, Hye-Jung Chung, Mark Raffeld, Pavalan Panneer Selvam, Leonille Schweizer, Arie Perry, David Samuel, Caterina Giannini, Aditya Ragunathan, Matthew P. Frosch, Michael S. Marshall, Daniel R. Boué, Kliment Donev, Stewart G. Neill, Igor Fernandes, Adam Resnick, Brian Rood, Thomas J. Cummings, Anne F. Buckley, Linda Szymanski, Osorio Lopes Abath Neto, Leor Zach, Howard Colman, Samuel Cheshier, Jennifer Ziskin, Manoj Tyagi, David Capper, Zied Abdullaev, Patrick J. Cimino, Martha Quezado, Drew Pratt, Kenneth Aldape
Publikováno v:
Acta Neuropathologica. 144:1175-1178
Autor:
Miriam Bornhorst, Augustine Eze, Surajit Bhattacharya, Ethan Putnam, M Isabel Almira‐Suarez, Christopher Rossi, Madhuri Kambhampati, Miguel Almalvez, Mariam Barseghyan, Nicole Del Risco, David Dotson, Joyce Turner, John S Myseros, Eric Vilain, Roger J Packer, Javad Nazarian, Brian Rood, Hayk Barseghyan
Publikováno v:
The Journal of Pathology.
Autor:
David Raleigh, William Chen, Abrar Choudhury, Mark Youngblood, Mei-Yin Polley, Calixto-Hope Lucas, Kanish Mirchia, Sybren Maas, Abigail Suwala, Minhee Won, James Bayley, Akdes Harmanci, Arif Harmanci, Tiemo Klisch, Minh Nguyen, Harish Vasudevan, Kathleen McCortney, Theresa Yu, Varun Bhave, Tai-Chung Lam, Jenny Pu, Gilberto Leung, Jason Chang, Haley Perlow, Joshua Palmer, Christine Haberler, Anna Berghoff, Matthias Preusser, Theodore Nicolaides, Christian Mawrin, Sameer Agnihotri, Adam Resnick, Brian Rood, Jessica Chew, Jacob Young, Lauren Boreta, Steve Braunstein, Jessica Schulte, Nicholas Butowski, Sandro Santagata, David Spetzler, Nancy Ann Oberheim Bush, Javier Villanueva-Meyer, James Chandler, David Solomon, C Rogers, Stephanie Pugh, Minesh Mehta, Penny Sneed, Mitchel Berger, Craig Horbinski, Michael McDermott, Arie Perry, Wenya Bi, Akash Patel, Felix Sahm, Stephen Magill
Background Surgery is the mainstay of treatment for meningioma, the most common primary intracranial tumor, but improvements in meningioma risk stratification are needed and current indications for postoperative radiotherapy are controversial. Recent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::27094e9a065536764ef315d2ec0010fb
https://doi.org/10.21203/rs.3.rs-2663611/v1
https://doi.org/10.21203/rs.3.rs-2663611/v1
Autor:
Miriam Bornhorst, Augustine Eze, Surajit Bhattacharya, Ethan Putnam, M. Isabel Almira-Suarez, Christopher Rossi, Madhuri Kambhampati, Miguel Almalvez, Mariam Barseghyan, Nicole Del Risco, David Dotson, Joyce Turner, John Myseros, Eric Vilain, Roger Packer, Javad Nazarian, Brian Rood, Hayk Barseghyan
Molecular characteristics of pediatric brain tumors have not only allowed for tumor subgrouping but have introduced novel treatment options for patients with specific tumor alterations. Therefore, an accurate histologic and molecular diagnosis is cri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::70b44c15230d4dc395e73fe41a3689c9
https://doi.org/10.21203/rs.3.rs-1879445/v1
https://doi.org/10.21203/rs.3.rs-1879445/v1
Autor:
Christopher Park, Roger Packer, Brian Rood, Lindsay Kilburn, Miriam Bornhorst, Christopher Rossi, Adriana Fonseca, Eugene Hwang
Publikováno v:
Neuro-Oncology. 24:vii144-vii144
BACKGROUND Monitoring for dissemination in medulloblastoma involves spinal MRIs (sMRIs) and lumbar punctures (LPs). The frequency and duration of these studies vary depending on risk of dissemination; general practice varies between and within instit
Autor:
Eugene Hwang, Fernanda Fortiz, Russell Cruz, Ashley Geiger, Melanie Grant, Haili Lang, Abeer Shibli, Sianna Burnett, Chris Lazarski, Jay Tanna, Chase McCann, Fahmida Hoq, Patrick Hanley, Lindsay Kilburn, Brian Rood, Roger Packer, Catherine Bollard
Publikováno v:
Neuro-Oncology. 24:i85-i86
BACKGROUND: The ReMIND trial hypothesizes that autologous T-cells specific for three tumor-associated antigens (TAA) -WT1, PRAME, and survivin- will be safe and elicit anti-tumor immunity in pediatric patients with CNS cancer. METHODS: Patients (n=25
Autor:
Emily Marshall, Sylvia Cheng, Julia Crowley, Shana McCormack, Brian Rood, Todd Hankinson, Michael DeCuypere, Sandy Lam, Stewart Goldman, Svenja Boekhoff, Hermann L Muller, Ryan Velasco, Phillip B Storm, Adam Resnick, Michael Prados, Sabine Mueller, Cassie Kline, Fatema Malbari
Publikováno v:
Neuro-Oncology. 24:i12-i12
Craniopharyngiomas are rare, histologically benign, sellar/parasellar tumors with significant tumor and therapy related morbidity and impairment in quality of life (QOL). We report survey results from patients/families affected by childhood-onset cra
Autor:
Melanie Grant, Maria Fortiz, Lu Wang, Haili Lang, Anushree Datar, Emily Reynolds, Madeleine Terpilowski, Ashley Geiger, Chris Lazarski, Jay Tanna, Adriana Pitino, Nan Zhang, Fahmida Hoq, Patrick Hanley, C Russell Cruz, Lindsay Kilburn, Roger Packer, Brian Rood, Catherine Bollard
Publikováno v:
Neuro-Oncology
Background Patients with relapsed CNS malignancies or DIPG face terrible prognoses. We hypothesized that T cells specific for 3 tumor-associated antigens (TAA), WT1, PRAME and survivin, would be safe and elicit anti-tumor immunity. Methods Patients (
Autor:
Melanie Grant, Maria Fernanda Fortiz, Lu Wang, Haili Lang, Anushree Datar, Emily Reynolds, Madeline Terpilowski, Chris Lazarski, Jay Tanna, Adriana Pitino, Nan Zhang, Fahmida Hoq, Patrick Hanley, Lindsay Kilburn, Roger Packer, Brian Rood, Catherine Bollard, Eugene Hwang
Publikováno v:
Neuro-Oncology
BACKGROUND Patients with relapsed CNS malignancies or DIPG face terrible prognoses. We hypothesized that T cells specific for 3 tumor-associated antigens (TAA), WT1, PRAME and survivin, would be safe and elicit anti-tumor immunity. METHODS Patients (
Autor:
Michal, Yalon, Brian, Rood, Tobey J, MacDonald, Geoff, McCowage, Rochelle, Kane, Shlomi, Constantini, Roger J, Packer
Publikováno v:
Pediatric bloodcancer. 60(1)
To determine the toxicity and efficacy of rapamycin and erlotinib for the treatment of recurrent pediatric low-grade gliomas (LGGs).Patients21 years of age with recurrent LGGs who had failed conventional treatment were eligible, including those with